Capital Flow Monitor · Sponsors · CIK 2111089

Mangrove Therapeutics Inc.

2108 N ST, SACRAMENTO, CA, 95816 · (650) 485-3618

Biotechnology · Corporation· inc. DELAWARE true 2025

Fit score

Offering

$5.0M

Sold

$2.5M

% sold

49.1%

Investors

9

Min investment

$25K

Exemption

506(b)

Filing history

FiledFormRuleOfferingSold% soldInvestors
2026-07-31 D ·current 506(b) $5.0M $2.5M 49.1% 9 EDGAR ↗

Related persons

Executive officers, directors and promoters, as filed.

  • Jin Li — Director, Sacramento, CA
  • Benjamin Zhiyi Chen — Executive Officer / Director, Sacramento, CA
  • Alexander Simon Green — Executive Officer, Sacramento, CA

Placement agents

  • No sales compensation reported — direct raise.

Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.